Related Experiment Video
Updated: Aug 7, 2026

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
Published on: April 13, 2018
Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein
Urmi Bandyopadhyay1, Urmi Bandhyopadhyay, Ana Maria Cuervo
1Department of Anatomy and Structural Biology, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Abstract:
Different conditions, ranging from genetic mutation to post-translational modification, result in the intracellular presence of misfolded or conformationally altered proteins. These abnormal proteins tend to organize in toxic oligomeric structures often resulting in cellular death. Alterations in the function of the surveillance systems that normally repair or remove abnormal proteins are the basis of many neurodegenerative disorders. In this review, we focus on such protein conformational disorders and on the role that altered function of intracellular proteolytic systems, in particular autophagy, plays in the evolution of these diseases. Using Parkinson disease as a main example, we recapitulate the different stages of this protein conformational disorder at the cellular level and relate them with changes in the different types of autophagy. Finally, we also comment on the effect that aggravating conditions, such as oxidative stress and aging, have on the functioning of the autophagic system and its ability to cope with altered proteins.
Insights
Misfolded proteins cause cellular damage and neurodegenerative diseases. This review explores how impaired autophagy contributes to these disorders, using Parkinson disease as a key example.
Area of Science:
- Cellular Biology
- Neuroscience
- Biochemistry
Background:
- Misfolded or conformationally altered proteins accumulate intracellularly due to genetic mutations or post-translational modifications.
- These abnormal proteins can form toxic oligomers, leading to cellular dysfunction and death.
- Dysregulation of cellular surveillance systems, responsible for protein repair or clearance, underlies many neurodegenerative disorders.
Purpose of the Study:
- To review protein conformational disorders and the role of intracellular proteolytic systems, particularly autophagy, in their progression.
- To examine the cellular stages of Parkinson disease as a model protein conformational disorder.
- To discuss the impact of aggravating factors like oxidative stress and aging on autophagy's ability to manage altered proteins.
Main Methods:
- Literature review focusing on protein conformational disorders and autophagy.
- Analysis of cellular mechanisms in Parkinson disease.
- Discussion of the interplay between aging, oxidative stress, and autophagic function.
Main Results:
- Altered protein conformations are implicated in cellular death and neurodegeneration.
- Impaired autophagy is a key factor in the pathogenesis of protein conformational disorders.
- Parkinson disease exemplifies the cellular consequences of protein misfolding and autophagic dysfunction.
- Aging and oxidative stress exacerbate autophagic system dysfunction, hindering clearance of abnormal proteins.
Conclusions:
- Autophagy plays a critical role in managing intracellular misfolded proteins and preventing neurodegeneration.
- Dysfunction in autophagic pathways contributes significantly to the development and progression of protein conformational disorders.
- Understanding the impact of aging and oxidative stress on autophagy is crucial for developing therapeutic strategies for neurodegenerative diseases.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Molecular Chaperones and Protein Folding
The...
Molecular Chaperones and Protein Folding
The...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

